Evidence map›Paper›PMID 22524785›Full record

ReviewAnnual review of neuroscience2012

Multiple functions of endocannabinoid signaling in the brain.

István Katona, Tamás F Freund

Abstract readReview
In one paragraph

Review in Annual review of neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 309 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
309citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

309 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Serotonin-endocannabinoid crosstalk selectively regulates inhibitory GABAergic inputs in the medial prefrontal cortex.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

249 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

István KatonaInstitute of Experimental Medicine, Hungarian Academy of Sciences, 1051 Budapest, Hungary. katona@koki.hu
Tamás F Freund

Funding

The Hippocampal Interneuron NetworkR01MH054671 · NIMH · RUTGERS THE STATE UNIV OF NJ NEWARK · PI BUZSAKI, GYORGY · 1997 to 2017
$5.2M
ENDOGENOUS GABAERGIC ACTIVITY IN THE MAMMALIAN BRAINR01NS030549 · NINDS · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI MODY, ISTVAN · 1992 to 2018
$4.5M
Endogenous GABAergic ActivityR37NS030549 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MODY, ISTVAN · 2001 to 2007
$2.7M
European Research Council 243153NIMH NIH HHS MH54671NIMH NIH HHS R01 MH054671NINDS NIH HHS NS30549NINDS NIH HHS R01 NS030549NINDS NIH HHS R37 NS030549Wellcome Trust 090946
6 · The paper itself

Abstract

Despite being regarded as a hippie science for decades, cannabinoid research has finally found its well-deserved position in mainstream neuroscience. A series of groundbreaking discoveries revealed that endocannabinoid molecules are as widespread and important as conventional neurotransmitters such as glutamate or GABA, yet they act in profoundly unconventional ways. We aim to illustrate how uncovering the molecular, anatomical, and physiological characteristics of endocannabinoid signaling has revealed new mechanistic insights into several fundamental phenomena in synaptic physiology. First, we summarize unexpected advances in the molecular complexity of biogenesis and inactivation of the two endocannabinoids, anandamide and 2-arachidonoylglycerol. Then, we show how these new metabolic routes are integrated into well-known intracellular signaling pathways. These endocannabinoid-producing signalosomes operate in phasic and tonic modes, thereby differentially governing homeostatic, short-term, and long-term synaptic plasticity throughout the brain. Finally, we discuss how cell type- and synapse-specific refinement of endocannabinoid signaling may explain the characteristic behavioral effects of cannabinoids.

Indexed as

AnimalsArachidonic AcidsBehavior, AnimalBrainEndocannabinoidsGlyceridesHumansLigandsModels, NeurologicalNeuronal PlasticityPolyunsaturated AlkamidesReceptors, CannabinoidSignal TransductionSynaptic TransmissionanandamideArachidonic AcidsEndocannabinoidsGlyceridesglyceryl 2-arachidonateLigandsPolyunsaturated AlkamidesReceptors, Cannabinoid

Identifiers

PMID22524785
PMCPMC4273654

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.